Promising Treatment Strategies for Neovascular AMD: Anti-VEGF Therapy

QR Code

Promising Treatment Strategies for Neovascular AMD: Anti-VEGF Therapy

None

Saved in:

Bibliographic Details
Main Authors:	Park, Young Gun, Ryu, Hyun Wook, Kang, Seungbum, Roh, Young Jung
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/26342
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Combined Therapies to Treat CNV in AMD: PDT + Anti-VEGF
by: Mataix, Jorge, et al.
Published: (2012)

Re-Treatment Strategies for Neovascular AMD: When to Treat? When to Stop?
by: Ozdek, Sengul, et al.
Published: (2012)

Biomarkers of Myopic Choroidal Neovascularization in Women, Determining the Clinical Course and Response to Anti-VEGF Therapy
by: A. V. Grigorieva, et al.
Published: (2021-06-01)

Principles of anti-VEGF dosing in the treatment of neovascular age-related macular degeneration
by: I. E. Ioshin, et al.
Published: (2019-08-01)

Long-Term Outcomes of Nonadherence to Anti-VEGF Therapy in Advanced Neovascular Age-Related Macular Degeneration
by: A. N. Kulikov, et al.
Published: (2022-10-01)

Association of neutrophil-to-lymphocyte ratio and neutrophil activation with treatment response in neovascular AMD
by: Alexander Kai Thomsen, et al.
Published: (2025-10-01)

Anti-VEGF therapy of neovascular age-related macular degeneration: from randomized trials to routine clinical practice
by: R. R. Fayzrakhmanov
Published: (2019-06-01)

Short-term Outcomes of Anti-VEGF therapy in Neovascular Age-related Macular Degeneration with Initially Low Visual Acuity
by: A. N. Kulikov, et al.
Published: (2025-03-01)

Structural and Functional Criteria of Neuroprotection Effectiveness after Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration
by: N. S. Zhajvoronok, et al.
Published: (2019-12-01)

Pharmacological Analysis of Resistance to Anti-VEGF Therapy
by: M. V. Budzinskaya, et al.
Published: (2019-01-01)

Treatments of Dry AMD
by: Chiou, George C. Y.
Published: (2012)

ANTI-ANGIOGENIC THERAPY IN PATIENTS WITH PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION
by: S. A. Korotkikh, et al.
Published: (2016-11-01)

Differential Visual Outcomes in Neovascular AMD Based on Ellipsoid Zone Integrity and Fluid Presence: Insights from a Phase III Trial
by: Justis P. Ehlers, et al.
Published: (2025-07-01)

Clinical Course and Results of Anti-VEGF Therapy of Retinopathy of Prematurity
by: L. A. Katargina, et al.
Published: (2021-04-01)

What's New in the Field Of AMD?
by: Gábor Márk Somfai
Published: (2023-04-01)

Inorganic nanomaterials as promising therapeutic agents for ocular neovascularization: Progress and perspectives
by: Yizhuo Geng, et al.
Published: (2025-08-01)

CLINICAL EFFECTIVENESS OF NEUROTRANSMITTERS PATIENTS WITH PRIMARY GLAUCOMA VEGF INHIBITOR IN PATIENTS WITH CHOROIDAL NEOVASCULARIZATION CAUSED BY DEGENERATIVE MYOPIA
by: L. P. Danilova, et al.
Published: (2016-09-01)

EFFECT OF ANTI-VEGF THERAPY ON THE STRUCTURAL STATE OF THE RETINA IN DIABETIC MACULAR EDEMA
by: M. M. Bikbov, et al.
Published: (2016-11-01)

Targeting retinal angiogenesis: sex differences in adverse reactions to anti-VEGF therapies
by: Eleonora Castellana, et al.
Published: (2025-07-01)

The complex model of risk and progression of AMD estimation
by: V. S. Akopyan, et al.
Published: (2014-07-01)

Quantitative Assessment of En&#x2011;face OCT&#x2011;Derived Minimum Intensity Fluid Changes Following Ranibizumab Biosimilar Therapy in Macular Neovascularization Secondary to nAMD and PCV
by: Sheth JU, et al.
Published: (2025-07-01)

Efficiency of antiangiogenic therapy for choroidal neovascularization in children
by: L. A. Katargina, et al.
Published: (2024-12-01)

Evaluation of Flowmetry Indicators in Patients with a Wet AMD Form during Antiangiogenic Therapy
by: N. Yu. Yousef, et al.
Published: (2019-12-01)

Efficiency of Retinoprotective Dry AMD Therapy with Neuroprotective Therapy: a Randomized Clinical Trials Meta-analysis
by: V. P. Erichev, et al.
Published: (2018-03-01)

Clinical Application of Drug Delivery Systems for Treating AMD
by: Kuno, Noriyuki, et al.
Published: (2012)

FEM amd BEM computing costs for acoustical problems
by: R. BOLEJKO, et al.
Published: (2014-03-01)

Neovascular Glaucoma
by: Cornish, Kurt Spiteri
Published: (2011)

Long-term results of anti-VEGF therapy in macular edema caused by central retinal vein occlusion
by: A. B. Galimova, et al.
Published: (2023-12-01)

THE FIRST EXPERIENCE OF USING ANTI-VEGF THERAPY PRIOR TO CATARACT SURGERY IN PATIENTS WITH DIABETIC MACULAR EDEMA
by: N. A. Malysheva
Published: (2018-10-01)

Polypoidal Choroidal Vasculopathy Treatment: Photodynamic Therapy, Anti-VEGF Monotherapy or Combination. Review of Clinical Studies
by: E. K. Pedanova, et al.
Published: (2019-06-01)

COMPARISON OF CLINICAL AND REAL-LIFE TRiaLS OF THE EFFECTIVENESS OF ANTI-VEGF THERAPY FOR age-related macular degeneration
by: M. V. Budzinskaya, et al.
Published: (2019-02-01)

In memoria di A.M.De Agostini( esploratore e geografo)
by: Dino Gribaudi
Published: (1961-12-01)

Osteonecrosis of bipartite patella following total knee arthroplasty without lateral release
by: Jung Ho Noh, et al.
Published: (2019-01-01)

Long-term results (60 months) of anti-VEGF therapy of macular diseases in real clinical practice. Part 1
by: E. V. Bobykin, et al.
Published: (2022-09-01)

Long-term results (60 months) of anti-VEGF therapy of macular diseases in real clinical practice. Part 2.
by: E. V. Bobykin, et al.
Published: (2022-12-01)

Treatment Cessation in Patients with Diabetic Maculopathy under Intravitreal Anti-VEGF Therapy Following a Treat-and-Extend Protocol
by: Lucia Saucedo, PhD, et al.
Published: (2025-11-01)

Corneal neovascularization: a modern view of molecular mechanisms and methods of therapy
by: G. S. Arzhimatova, et al.
Published: (2023-07-01)

The role of optical coherence tomography angiography biomarkers in assessing the outcome of long-term anti-VEGF therapy of diabetic macular edema
by: A. Zh. Fursova, et al.
Published: (2022-01-01)

Mevalonate pathway-triggered phase transition of injectable hydrogel for cholesterol-downregulated therapy of osteoarthritis
by: Akhmad Irhas Robby, et al.
Published: (2025-09-01)

Factors determining the compliance of patients receiving anti-VEGF therapy for macular diseases with long-term follow-up in real-life practice
by: E. V. Bobykin, et al.
Published: (2021-03-01)